Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Plaque Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01636687
What this trial is testing

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 182
Not applicableStudy completedNCT05388916
What this trial is testing

A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Novartis Pharmaceuticals 42
Large-scale testing (Phase 3)Study completedNCT06398652
What this trial is testing

Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Taizhou Mabtech Pharmaceutical Co.,Ltd 336
Testing effectiveness (Phase 2)WithdrawnNCT02011269
What this trial is testing

TSO for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Coronado Biosciences, Inc.
Testing effectiveness (Phase 2)Study completedNCT03764475
What this trial is testing

Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Arcutis Biotherapeutics, Inc. 332
Post-approval studies (Phase 4)Study completedNCT02148640
What this trial is testing

The NOR-SWITCH Study

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisPsoriatic Arthritis+3 more
Diakonhjemmet Hospital 482
Testing effectiveness (Phase 2)Study completedNCT00645905
What this trial is testing

Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 148
Not applicableStudy completedNCT02274363
What this trial is testing

Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis

Who this might be right for
PsoriasisPlaque
Janssen Pharmaceutica 1,131
Not applicableStudy completedNCT04818385
What this trial is testing

Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Taiwan

Who this might be right for
Psoriasis
AbbVie 240
Testing effectiveness (Phase 2)Study completedNCT00823693
What this trial is testing

Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

Who this might be right for
Psoriasis
Revotar Biopharmaceuticals AG 107
Not applicableNot Yet RecruitingNCT07581418
What this trial is testing

Comparison of Methotrexate and Tofacitinib in Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Pak Emirates Military Hospital 88
Large-scale testing (Phase 3)Study completedNCT01412944
What this trial is testing

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 43
Testing effectiveness (Phase 2)Study completedNCT03384745
What this trial is testing

A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Bond Avillion 2 Development LP 313
Large-scale testing (Phase 3)Study completedNCT02698475
What this trial is testing

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 44
Large-scale testing (Phase 3)Looking for participantsNCT07362017
What this trial is testing

Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
Vanda Pharmaceuticals 300
Post-approval studies (Phase 4)Ended earlyNCT00739882
What this trial is testing

TRUST Study: Raptiva ® in Hand & Foot Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 76
Large-scale testing (Phase 3)Study completedNCT01729754
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited 1,090
Not applicableStudy completedNCT00422617
What this trial is testing

Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients

Who this might be right for
Chronic Plaque Psoriasis
Uni-Pharma 40
Large-scale testing (Phase 3)Study completedNCT01309737
What this trial is testing

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 960
Large-scale testing (Phase 3)Study completedNCT00233662
What this trial is testing

Safety and Tolerability of Repeat Courses of IM Alefacept

Who this might be right for
Chronic Plaque Psoriasis
Biogen 400
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation